Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Sponsored
Interactive Tools
Learning Modules
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Jared Weiss, MD, UNC Lineberger Comprehensive Cancer Center
home
Articles
Next Steps for RET-Mutated Medullary Thyroid Cancer
November 16th 2020
Recent Approval of Selpercatinib in RET-Mutated MTC
November 16th 2020
Multikinase TKIs in Medullary Thyroid Cancer
November 16th 2020
Actionable Driver Mutations in Medullary Thyroid Cancer
November 16th 2020
Epidemiology of Medullary Thyroid Cancer
November 16th 2020
Next Steps for RET Fusion+ NSCLC
November 16th 2020
RET Fusion+ NSCLC and COVID-19
November 16th 2020
Intracranial Response Rates from RET Inhibitors
November 16th 2020
Importance of Frontline RET Inhibition in NSCLC
November 16th 2020
FDA Approval of RET Inhibitors in NSCLC
November 16th 2020
Best Practices for NGS Selection in NSCLC
November 16th 2020
Use of Liquid Biopsy for RET Detection
November 16th 2020
Optimal Detection of RET Fusions
November 16th 2020
Multikinase TKIs for RET Fusion+ NSCLC
November 16th 2020
Biology of RET Genetic Alterations
November 16th 2020